Sangeet Ghai, MD, FRCR, presented “Current and Emerging Imaging Tools for Improving Risk Assessment, Selection of Patients for Biopsy, and Tissue Sampling” during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019 in Boston, Massachusetts.
How to cite: Sangeet, Ghai. “Current and Emerging Imaging Tools for Improving Risk Assessment, Selection of Patients for Biopsy, and Tissue Sampling” October 3, 2019. Accessed Nov 2024. https://grandroundsinurology.com/current-and-emerging-imaging-tools-for-improving-risk-assessment-selection-of-patients-for-biopsy-and-tissue-sampling/
Current and Emerging Imaging Tools for Improving Risk Assessment, Selection of Patients for Biopsy, and Tissue Sampling – Summary:
Sangeet Ghai, MD, FRCR, Associate Professor of Abdominal Imaging at Toronto General Hospital, outlines improvements in ultrasound technology that could significantly improve real-time prostate cancer diagnostics. He discusses several studies demonstrating the diagnostic capability of the 29Mhz microultrasound, how it compares to mpMRI, and how this new technology could streamline prostate cancer diagnostics by reducing the need to conduct MRI fusion biopsies.
About The 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer:
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a multi-day, multi-disciplinary forum dedicated to informing healthcare stakeholders about topics including in-vitro fluid- and tissue-based molecular diagnostics, novel observation strategies such as active surveillance, and novel therapeutic interventions. Along with this forum’s efforts to form a consensus on the future of prostate diagnostics and precision care, it aims to create an educational and research strategy for its realization. Dr. Ghai presented this lecture during the 4th iteration of this Summit in 2019.
ABOUT THE AUTHOR
Dr. Sangeet Ghai is the Deputy Chief of Research and Associate Professor in the Joint Department of Medical Imaging (JDMI) at the University of Toronto in Ontario, Canada. He is affiliated with the Cancer Clinical Research Unit at the Princess Margaret Cancer Centre, also in Toronto. Dr Ghai completed his postgraduate training in India, including a senior residency at the All India Institute of Medical Sciences in New Delhi. His main areas of interest and research include prostate imaging and intervention. He is actively involved in developing prostate MRI techniques, high-resolution ultrasound imaging of the prostate, and in-bore focal treatments for intermediate-risk prostate cancer. He is also interested in MR-guided focused ultrasound surgery and MR-guided focal laser ablation.
